Lirum Therapeutics, Inc. (LRTX)
Lirum Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price
$5.00
Shares Offered
5,000,000
Deal Size
$25.00M
Lirum Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
45.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLRTX News
- 9 months ago - Oncology and autoimmune biotech Lirum Therapeutics files for a $25 million IPO - Renaissance Capital
- 9 months ago - Lirum Therapeutics IPO Registration Document (S-1) - SEC